Researchers have been returning to researching the benefits of mind altering substances including MDMA, psilosyben and Ketamine relieving symptoms related to depression, PTSD and end-of-life anxiety. While Ketamine assisted therapy is currently the only psychadelic intervention currently available in the US, there is hope, based on research results, that additional treatment options may soon be available through licensed practitioners.
I have currently attended more than forty hours of psychedelic assisted training focused on treating depression, trauma and anxiety. And while my work is currently limited to Ketamine assisted therapy, I am committed to additional training as research unfolds.
I have currently attended more than forty hours of psychedelic assisted training focused on treating depression, trauma and anxiety. And while my work is currently limited to Ketamine assisted therapy, I am committed to additional training as research unfolds.